Home › Funds › WITTENBERG INVESTMENT MANAGEMENT, INC. › LFCR
WITTENBERG INVESTMENT MANAGEMENT, INC. position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
WITTENBERG INVESTMENT MANAGEMENT, INC. reported holding 305,315 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.71% of its reported portfolio and ranking #22 among its reported holdings. WITTENBERG INVESTMENT MANAGEMENT, INC. has disclosed LFCR holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How WITTENBERG INVESTMENT MANAGEMENT, INC.'s LFCR position evolved
WITTENBERG INVESTMENT MANAGEMENT, INC. first disclosed a stake in LFCR in Q2 2024 at 14,929 shares (US$77K). The position peaked in Q3 2026 at 305,315 shares, worth US$2.0M. Across 10 filings, WITTENBERG INVESTMENT MANAGEMENT, INC. increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 305,315 shares valued at US$2.0M — a reduction of -8,700 shares quarter over quarter.. Notable position changes include a 288% increase in Q3 2024 (shares rose 51% over the following quarter), a 81% trim in Q4 2024 (shares fell 5% over the following quarter), a 1289% increase in Q1 2026 (shares rose 41% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 14.93K | $76.59K | New |
| Q3 2024 | 57.90K | $285.43K | Add |
| Q4 2024 | 11.22K | $83.39K | Reduce |
| Q1 2025 | 12.22K | $86.05K | Add |
| Q2 2025 | 17.22K | $139.85K | Add |
| Q3 2025 | 17.22K | $126.76K | Hold |
| Q4 2025 | 21.72K | $177.69K | Add |
| Q1 2026 | 301.81K | $1.12M | Add |
| Q2 2026 | 314.01K | $1.65M | Add |
| Q3 2026 | 305.31K | $2.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LFCR and 13F data
LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 20 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), Greenhaven Road Investment Management, L.P. (US$18.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LFCR
- WYNNEFIELD CAPITAL INC 4.70M sh · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M sh · $23.42M · Q2 2026
- Greenhaven Road Investment Management, L.P. 2.87M sh · $18.88M · Q3 2026
- 325 CAPITAL LLC 2.90M sh · $15.20M · Q2 2026
- DCF Advisers, LLC 376.50K sh · $2.48M · Q3 2026
More on WITTENBERG INVESTMENT MANAGEMENT, INC.
FAQ
How long has WITTENBERG INVESTMENT MANAGEMENT, INC. held LFCR?
WITTENBERG INVESTMENT MANAGEMENT, INC. has disclosed LFCR holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is WITTENBERG INVESTMENT MANAGEMENT, INC.'s current position in LFCR?
As of Q3 2026, WITTENBERG INVESTMENT MANAGEMENT, INC. holds 305.31K shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $2.01M, representing 0.71% of its reported portfolio and ranking #22.
Has WITTENBERG INVESTMENT MANAGEMENT, INC. been buying or selling LFCR?
In the latest 13F filing (Q3 2026), WITTENBERG INVESTMENT MANAGEMENT, INC. reduced its position in LFCR. The position peaked in Q3 2026 at 305.31K shares.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.